These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 38750718

  • 1. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway.
    He H, He M, Wang Y, Xiong H, Xiong Y, Shan M, Liu D, Guo Z, Kou Y, Zhang Y, Yang M, Lian J, Sun L, He F.
    Exp Cell Res; 2024 Jun 01; 439(1):114094. PubMed ID: 38750718
    [Abstract] [Full Text] [Related]

  • 2. Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin.
    Wu Y, Ni Z, Yan X, Dai X, Hu C, Zheng Y, He F, Lian J.
    Autophagy; 2016 Jul 02; 12(7):1105-17. PubMed ID: 27097054
    [Abstract] [Full Text] [Related]

  • 3. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
    Zhang N, Wu Y, Lyu X, Li B, Yan X, Xiong H, Li X, Huang G, Zeng Y, Zhang Y, Lian J, Ni Z, He F.
    Cancer Lett; 2017 Nov 28; 409():81-90. PubMed ID: 28889000
    [Abstract] [Full Text] [Related]

  • 4. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway.
    You X, Cao X, Lin Y.
    Front Biosci (Landmark Ed); 2019 Jun 01; 24(7):1190-1202. PubMed ID: 31136975
    [Abstract] [Full Text] [Related]

  • 5. RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.
    Huang H, Chen T, Zhou Y, Geng L, Shen T, Zhou L, Zheng S.
    Int J Med Sci; 2018 Jun 01; 15(14):1648-1657. PubMed ID: 30588188
    [Abstract] [Full Text] [Related]

  • 6. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
    Zhang Q, Wang X, Cao S, Sun Y, He X, Jiang B, Yu Y, Duan J, Qiu F, Kang N.
    Biomed Pharmacother; 2020 Aug 01; 128():110245. PubMed ID: 32454290
    [Abstract] [Full Text] [Related]

  • 7. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma.
    Li J, Li O, Kan M, Zhang M, Shao D, Pan Y, Zheng H, Zhang X, Chen L, Liu S.
    Mol Med Rep; 2015 Sep 01; 12(3):4572-4577. PubMed ID: 26081696
    [Abstract] [Full Text] [Related]

  • 8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 9. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.
    BMC Cancer; 2012 May 04; 12():166. PubMed ID: 22559167
    [Abstract] [Full Text] [Related]

  • 10. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.
    Chen L, Ye HL, Zhang G, Yao WM, Chen XZ, Zhang FC, Liang G.
    PLoS One; 2014 May 04; 9(1):e85771. PubMed ID: 24465696
    [Abstract] [Full Text] [Related]

  • 11. Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA.
    Tai CJ, Jassey A, Liu CH, Tai CJ, Richardson CD, Wong SH, Lin LT.
    Cells; 2020 Apr 08; 9(4):. PubMed ID: 32276448
    [Abstract] [Full Text] [Related]

  • 12. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM, Cheung KC, Cheung YC, Man K, Lui VW, Tsao SW, Feng Y.
    Biochim Biophys Acta; 2015 Mar 08; 1852(3):541-51. PubMed ID: 25496992
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.
    Int J Cancer; 2012 Aug 01; 131(3):548-57. PubMed ID: 21858812
    [Abstract] [Full Text] [Related]

  • 14. An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells.
    Xie Y, Fan S, Ni D, Wan W, Xu P, Ding Y, Zhang R, Lu J, Zhang N, Zhang Y, Xiao W, Zhao K, Luo C.
    Bioorg Med Chem; 2023 Apr 15; 84():117262. PubMed ID: 37018878
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma via AMPK-FOXO1-ULK1 signaling axis-mediated autophagy.
    Xiao Q, Liu H, Wang HS, Cao MT, Meng XJ, Xiang YL, Zhang YQ, Shu F, Zhang QG, Shan H, Jiang GM.
    Theranostics; 2020 Apr 15; 10(22):10245-10261. PubMed ID: 32929346
    [Abstract] [Full Text] [Related]

  • 16. Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib.
    Huang Y, Wang K, Gu C, Yu G, Zhao D, Mai W, Zhong Y, Liu S, Nie Y, Yang H.
    Oncol Rep; 2018 Sep 15; 40(3):1525-1532. PubMed ID: 30015938
    [Abstract] [Full Text] [Related]

  • 17. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Oncotarget; 2014 May 15; 5(9):2853-63. PubMed ID: 24797310
    [Abstract] [Full Text] [Related]

  • 18. Silencing of ATG4D suppressed proliferation and enhanced cisplatin-induced apoptosis in hepatocellular carcinoma through Akt/Caspase-3 pathway.
    Zhao JY, Li XY, Liu TD, Liang B, Huang Y, Li W.
    Mol Cell Biochem; 2021 Nov 15; 476(11):4153-4159. PubMed ID: 34313895
    [Abstract] [Full Text] [Related]

  • 19. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
    Song L, Luo Y, Wang X, Almutairi MM, Pan H, Li W, Liu Y, Wang Q, Hong M.
    Mol Med Rep; 2019 Nov 15; 20(5):4654-4664. PubMed ID: 31545468
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
    Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang SS, Deng WJ, Zhao X, Wu MC, Wei LX.
    J Mol Med (Berl); 2013 Apr 15; 91(4):473-83. PubMed ID: 23052483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.